Home › NDC Lookup › RxCUI directory › RxCUI 628958

Potassium chloride 10 MEQ Extended Release Oral Tablet [Klor-Con] — RxCUI 628958

RxNorm drug concept · Semantic branded drug
RxCUI 628958 Semantic branded drug · SBD ● Current RxNorm concept 4 FDA products 10 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI628958
Official namePotassium chloride 10 MEQ Extended Release Oral Tablet [Klor-Con]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asKlor-Con 10 MEQ Extended Release Oral Tablet; K+ Chloride 10 MEQ Extended Release Oral Tablet [Klor-Con]; Klor-Con M 750 MG Extended Release Oral Tablet; Pot Chloride 10 MEQ Extended Release Oral Tablet [Klor-Con]
FDA products mapped4
Package NDCs mapped10
Reported Medicaid activity (SDUD)4,966 prescriptions · 28 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Potassium Chloride: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It treats and prevents low potassium. Doctors often use it when you take diuretics or lose fluids through diarrhea or vomiting and food alone isn't enough. The injection is used in...
  • Take tablets and capsules with meals, not on an empty stomach, to protect your stomach. Powders and liquids need to be diluted first. Follow your prescriber's directions and keep y...
  • The most common issue is stomach upset. Taking it with food helps. Call your doctor if you have severe vomiting, belly pain, swelling or bleeding, since that can mean an ulcer or b...
  • Check with me first. Blood pressure medicines such as ACE inhibitors and ARBs, spironolactone, and NSAIDs can raise potassium. Triamterene and amiloride should be avoided with it.
📖 Read our full Potassium Chloride guide →

🕸️ Concept Web — How Potassium chloride 10 MEQ Extended Release Oral... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Potassium chloride 10 MEQ Extended Release Oral Tablet [Klor-Con] RxCUI 628958

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Potassium chloride 8591
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Klor-Con 217905
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Potassium chloride Extended Release Oral Tablet 373524
    • Potassium chloride Oral Product 1160489
    • Potassium chloride Pill 1160490
    • Potassium chloride Extended Release Oral Tablet [Klor-Con] 628957
    • Klor-Con Oral Product 1172124
    • Klor-Con Pill 1172125
    • Extended Release Oral Tablet 316945
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Brand-Name Concepts

  • Potassium chloride 10 MEQ [Klor-Con] SBDC · 628956
  • Potassium chloride Extended Release Oral Tablet [Klor-Con] SBDF · 628957
  • Klor-Con Oral Product SBDG · 1172124
  • Klor-Con Pill SBDG · 1172125
  • Klor-Con BN · 217905

📦 FDA Products & Package NDCs

4 products · 10 package NDCs
10 package NDCs map to RxCUI 628958 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00245-0835-11 100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0245-... KLOR-CON Upsher-Smith Laboratories, LLC 2025-08-15
00245-0835-15 500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0245-... KLOR-CON Upsher-Smith Laboratories, LLC 2025-08-15
00245-0836-11 100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0245-... KLOR-CON Upsher-Smith Laboratories, LLC 2025-08-15
00245-0836-15 500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0245-... KLOR-CON Upsher-Smith Laboratories, LLC 2025-08-15
00245-5315-01 100 BLISTER PACK in 1 BLISTER PACK (0245-5315-01) / 1 TABLE... KLOR-CON Upsher-Smith Laboratories, LLC 2019-06-21
00245-5315-11 100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0245-... KLOR-CON Upsher-Smith Laboratories, LLC 2019-06-21
00245-5315-15 500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0245-... KLOR-CON Upsher-Smith Laboratories, LLC 2019-06-21
00245-5316-01 100 BLISTER PACK in 1 BLISTER PACK (0245-5316-01) / 1 TABLE... KLOR-CON Upsher-Smith Laboratories, LLC 2019-06-21
00245-5316-11 100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0245-... KLOR-CON Upsher-Smith Laboratories, LLC 2019-06-21
00245-5316-15 500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0245-... KLOR-CON Upsher-Smith Laboratories, LLC 2019-06-21
Observed labelers: Upsher-Smith Laboratories, LLC (10) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.